SlimCarb assists in the treatment of obesity by inhibiting salivary, pancreatic and intestinal a-glycosidase enzyme activity, thereby promoting a delayed absorption of carbohydrates and glucose. In addition, Slimcarb has an inhibitory action on pancreatic lipase - an enzyme responsible for digesting fat.
